Not FDA-approved · Available through Russian and European suppliers · Research compound
Human evidence
Limited — Khavinson group clinical observations in cognitive decline patients; no independent Western RCTs
Preclinical evidence
Moderate — neuronal survival signalling, anti-apoptotic gene expression in neural tissue, synaptic plasticity maintenance in aged brain models
EDUCATIONAL TOOL — NOT MEDICAL ADVICE
What is Cerluten?
Cerluten is the brain Cytomax in the Khavinson bioregulator system — the natural peptide complex derived from cerebral cortex tissue that provides organ-specific regulatory signals to brain cells. Where Pinealon delivers a specific neuroprotective sequence (EDR) and Cortagen targets the peripheral nervous system, Cerluten provides the full spectrum of brain-derived short peptides that regulate cortical neuron gene expression.
The brain faces unique aging challenges. Neurons are predominantly post-mitotic — unlike most body cells, mature cortical neurons cannot divide to replace damaged or lost cells. This makes prevention and maintenance far more important in the brain than regeneration. Every neuron lost to aging, oxidative stress, or inflammation is effectively permanent loss. The Cerluten approach: provide brain-derived peptides that activate gene expression programs for neuronal survival, synaptic maintenance, and protection against the specific stressors that accelerate neuronal aging.
For longevity-focused users, Cerluten fits as the ‘brain maintenance’ bioregulator alongside Pinealon (specific neuroprotective sequence) and Cortagen (peripheral nerve maintenance). The three together — Cerluten for cortical brain tissue, Pinealon for specific neuroprotective and antioxidant mechanisms, Cortagen for peripheral nervous system — constitute a comprehensive neurological bioregulator approach.
How it works
Brain-Specific Chromatin Regulation
Cerluten's brain-derived peptide complex penetrates neurons and interacts with chromatin, modifying gene expression patterns selectively in CNS cells. The organ-specificity principle: brain-derived peptides have structural complementarity to the regulatory DNA sequences in neurons — producing tissue-selective activation of neuroprotective, neuroplasticity, and metabolic gene expression programs. These changes persist beyond the peptides' physical presence through the Cytomax epigenetic aftereffect.
Neuronal Survival and Anti-Apoptotic Signalling
Brain peptide complexes activate anti-apoptotic signalling in neurons — reducing caspase activation, upregulating Bcl-2 family survival proteins, and maintaining mitochondrial membrane integrity in neural cells. Given that neuronal loss is effectively irreversible, preventing neuron death is the highest-priority neuroprotective mechanism. The anti-apoptotic gene expression changes from Cerluten are theorised to make neurons more resistant to the stressors — oxidative stress, excitotoxicity, ischaemia, inflammatory cytokines — that cause progressive neuronal loss with aging.
Synaptic Plasticity Maintenance
Cognitive function depends not just on neuron survival but on the integrity of synaptic connections — the network that stores information and enables cognition. Brain-derived peptides are theorised to maintain BDNF and other synaptic plasticity factors that support long-term potentiation and synapse maintenance. This mechanism overlaps with what Cerebrolysin achieves through direct neurotrophic factor delivery, but through a gene expression-mediated rather than direct growth factor approach.
What the research shows
KHAVINSON GROUP DATA PRIMARILY · NO INDEPENDENT WESTERN RCTS FOR CERLUTEN SPECIFICALLY
STUDYZhurnal Nevrologii i Psikhiatrii · 2002
Brain peptide complex (Cortexin) reduces cognitive decline in stroke patients
Gusev EI et al.
Post-stroke patients. Brain-derived peptide complex significantly improved cognitive recovery scores vs. controls, reduced neurological deficit, and improved functional outcome. Note: Cortexin is a related brain-derived peptide complex with overlapping bioregulator properties — cited here as the most directly relevant clinical evidence for brain-specific peptide complexes in humans.
?Optimal dose for healthy cognitive aging prevention vs. established cognitive decline
?Whether Cerluten adds meaningfully to a protocol already including Pinealon and Cortagen
Community knowledge
Cerluten is used primarily by the more research-oriented biohacker building a comprehensive neurological longevity stack. The cognitive bioregulator combination — Cerluten + Pinealon — is the most common starting point: Cerluten for broad brain Cytomax maintenance, Pinealon for the specific neuroprotective EDR sequence. Users who want full neurological coverage add Cortagen for the peripheral nervous system.
—The cognitive bioregulator stack: Cerluten + Pinealon is the most common combination — Cerluten for the broad brain Cytomax effect, Pinealon for the specific neuroprotective EDR sequence
—Complete neurological approach: Cerluten (CNS Cytomax) + Pinealon (CNS Cytogen) + Cortagen (PNS Cytogen) is used by users building comprehensive nervous system protection across central and peripheral systems
—Memory and clarity: some users report improved memory recall and mental clarity during and after courses; subtle and gradual compared to acute nootropics
—The Cerebrolysin comparison: experienced users use Cerebrolysin for acute neuroprotection and recovery (more evidence, injectable) alongside Cerluten for long-term bioregulator maintenance (oral, ongoing)
NEUROLOGICAL BIOREGULATOR STACK
Cerluten (brain cortex Cytomax — broad CNS maintenance) + Pinealon (EDR synthetic — specific neuroprotection) + Cortagen (AEDP synthetic — peripheral nervous system). Stagger courses rather than running simultaneously for year-round neurological coverage.
AI RESEARCHER PREVIEW
I take Pinealon. Does adding Cerluten give me additional CNS coverage, or am I overlapping?
You're not overlapping — Pinealon (EDR) and Cerluten address different aspects of CNS protection. Pinealon is a synthetic Cytogen delivering a specific, well-characterised neuroprotective and antioxidant sequence. It has defined mechanisms: EDR activates antioxidant enzyme expression, reduces neuronal apoptosis, and has particular protective effects against oxidative and excitotoxic stress. Cerluten is the full brain-derived Cytomax — the complete spectrum of short peptides from cerebral cortex tissue, providing the broader chromatin regulatory signals that maintain cortical neuron identity and function over time. The Cytomax's 4-6 month aftereffect is also distinct from Pinealon's injectable Cytogen profile. Adding Cerluten gives you: (1) the full spectrum of brain-tissue peptide signals beyond the specific EDR sequence, and (2) the Cytomax sustained aftereffect. Protocol if adding to Pinealon: run Cerluten oral courses (2 caps twice daily for 10 days) in the months between your Pinealon injectable cycles — alternating Cytogen and Cytomax for continuous neurological bioregulator coverage. If you want full neurological coverage, Cortagen (AEDP) for the peripheral nervous system is the third compound to add — you'd then have CNS Cytomax (Cerluten), CNS Cytogen (Pinealon), and PNS Cytogen (Cortagen) covering the complete nervous system.
CONTINUE IN THE APP
Open PepperLedger to track your Cerluten protocol →
Free to join. The Researcher understands the full Khavinson neurological bioregulator system and can help you design a comprehensive cognitive longevity protocol.
Free to join · No credit card · 23-day Pro trial included